SMS Pharma Ltd Receives EIR From USFDA For API Facility At Kandivalasa, Andhra Pradesh

SMS Pharmaceuticals Ltd has announced successful closure of inspection with the receipt of Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for the inspection conducted at our API facility situated at Kandivalasa, Andhra Pradesh during the period 13th January 2020 to 17th January, 2020. This facility predominantly caters regulated markets including USA.

Shares of SMS PHARMACEUTICALS LTD. was last trading in BSE at Rs.34.35 as compared to the previous close of Rs. 37.4. The total number of shares traded during the day was 2766 in over 165 trades.

The stock hit an intraday high of Rs. 36.75 and intraday low of 34.35. The net turnover during the day was Rs. 97696.-Equity Bulls